Literature DB >> 4089799

White blood cell count and haematocrit as predictors of coronary recurrence after myocardial infarction.

G D Lowe, S G Machado, W F Krol, B A Barton, C D Forbes.   

Abstract

Baseline white blood cell count (WCC) and haematocrit were examined in relation to recurrent coronary events and to all-cause mortality in 2026 persons enrolled in the first Persantin-Aspirin Reinfarction Study (PARIS-1) 2-60 months after myocardial infarction. WCC was strongly related to coronary recurrence (relative risk 3.5 for men with WCC greater than or equal to 9 X 10(9)/l vs men with WCC less than 5 X 10(9)/l) and total mortality (relative risk 2.6). No such relationships were found for haematocrit. WCC correlated also with cigarette-smoking, diuretic use, serum cholesterol and uric acid; however, the associations with coronary recurrence and total mortality persisted on multiple linear and logistic regression analysis including these variables and treatment group (p less than 0.001). WCC is therefore an easily-measured prognostic variable in survivors of myocardial infarction. Furthermore, we suggest that white blood cells may promote myocardial ischaemia by capillary plugging and/or release of toxic oxygen metabolites.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4089799

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  14 in total

1.  Beta-adrenoceptor antagonists enhance white blood cell aggregation in patients with ischaemic heart disease.

Authors:  A B Bridges; T H Pringle; G P McNeill; R Tavendale; J J Belch
Journal:  Br J Clin Pharmacol       Date:  1992-09       Impact factor: 4.335

2.  Flow resistance of individual neutrophils in coronary artery disease: decreased pore transit times in acute myocardial infarction.

Authors:  R M Bauersachs; G Moessmer; C Koch; F J Neumann; H J Meiselman; C Pfafferott
Journal:  Heart       Date:  1997-01       Impact factor: 5.994

Review 3.  Components of the complete blood count as risk predictors for coronary heart disease: in-depth review and update.

Authors:  Mohammad Madjid; Omid Fatemi
Journal:  Tex Heart Inst J       Date:  2013

Review 4.  Inflammation, infection and atherosclerosis: do antibacterials have a role in the therapy of coronary artery disease?

Authors:  J L Mehta; F Romeo
Journal:  Drugs       Date:  2000-02       Impact factor: 9.546

5.  Subtle increase in leukocyte counts in association with drinking and smoking habits.

Authors:  O Inoue; K Seiji; M Takahashi; K Kudo; H Nakatsuka; T Watanabe; Y Uchida; M Ikeda
Journal:  Int Arch Occup Environ Health       Date:  1995       Impact factor: 3.015

Review 6.  Weighing the evidence for infection as a risk factor for coronary heart disease.

Authors:  C J O'Donnell; D Levy
Journal:  Curr Cardiol Rep       Date:  2000-07       Impact factor: 2.931

7.  Systemic Inflammatory Response Syndrome Predicts Mortality in Acute Coronary Syndrome without Congestive Heart Failure.

Authors:  Matías José Fosco; Victoria Ceretti; Daniel Agranatti
Journal:  West J Emerg Med       Date:  2010-09

8.  Clinical features of early recurrent myocardial infarction.

Authors:  Kenichi Sakakura; Norifumi Kubo; Junya Ako; Nahoko Ikeda; Hiroshi Funayama; Taishi Hirahara; Hiroshi Wada; Yoshitaka Sugawara; Takanori Yasu; Masanobu Kawakami; Shin-ichi Momomura
Journal:  Heart Vessels       Date:  2009-09-27       Impact factor: 2.037

9.  Serum levels of soluble intercellular adhesion molecule-1 (ICAM-1, CD54) in patients with non-small-cell lung cancer: correlation with histological expression of ICAM-1 and tumour stage.

Authors:  A Grothey; P Heistermann; S Philippou; R Voigtmann
Journal:  Br J Cancer       Date:  1998-03       Impact factor: 7.640

10.  Elevated white cell count in acute coronary syndromes: relationship to variants in inflammatory and thrombotic genes.

Authors:  Connie E Byrne; Anthony Fitzgerald; Christopher P Cannon; Desmond J Fitzgerald; Denis C Shields
Journal:  BMC Med Genet       Date:  2004-06-01       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.